Skip to search formSkip to main contentSkip to account menu

Leuvectin

National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Cancer VaccinesIL-2 plasmid DNA/lipid complexInterleukin-2

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Intratumoral administration of a 1,2‐dimyristyloxypropyl‐3‐ dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin‐2 gene in the treatment of…
Leuvectin (Vical Inc., San Diego, CA) is a gene transfer product in which a plasmid encoding the human interleukin‐2 (IL‐2) gene… 
Review
2001
Review
2001
Leuvectin Vical Inc.
Vical's Leuvectin, a plasmid DNA expression vector encoding interleukin-2 (IL-2) complexed with a lipid delivery vehicle (DMRIE… 
Highly Cited
1999
Highly Cited
1999
Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience.
PURPOSE We have completed a phase I study, followed by three phase I/II studies, in patients with metastatic melanoma, renal cell… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)